Retraction: Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway
Retraction of ‘Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway’ by ZhongYu Jiang et al. , RSC Adv. , 2019, 9 , 35473–35482, https://doi.org/10.1039/C9RA05933D.
Saved in:
| Published in | RSC advances Vol. 14; no. 21; p. 14514 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
England
Royal Society of Chemistry
02.05.2024
The Royal Society of Chemistry |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Summary: | Retraction of ‘Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma
via
Wnt/β-catenin signaling pathway’ by ZhongYu Jiang
et al.
,
RSC Adv.
, 2019,
9
, 35473–35482, https://doi.org/10.1039/C9RA05933D. |
|---|---|
| Bibliography: | retraction ObjectType-Correction/Retraction-1 SourceType-Scholarly Journals-1 content type line 14 content type line 23 |
| ISSN: | 2046-2069 2046-2069 |
| DOI: | 10.1039/D4RA90047B |